As one of the first biotechnology companies in Germany, biosyn was founded in 1984 and specializes in keyhole limpet hemocyanin products and high-dose selenium injectable pharmaceuticals. Since its founding, the company has developed into a pharmaceutical enterprise with subsidiaries in …
Month: February 2018
6750 Shares in iShares NASDAQ Biotechnology Index (IBB) Acquired by Navellier & Associates Inc
iShares NASDAQ Biotechnology Index logo Navellier & Associates Inc acquired a new stake in shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 6,750 shares …
iShares NASDAQ Biotechnology Index (IBB) Shares Bought by Main Management LLC
iShares NASDAQ Biotechnology Index logo Main Management LLC boosted its holdings in iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 190.5% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional …
It’s OK to use nasal spray flu vaccine again, US panel says
Federal panel says it’s OK for doctors to start using a kid-friendly nasal spray flu vaccine again
Could ‘Grey’s Anatomy’ skew your hospital expectations?
Medical outcomes on TV vary from real life, a new study notes.
Valuation Dashboard: Healthcare – Update
Biotechnology is the only Healthcare industry looking undervalued regarding historical averages in 2 valuation factors (P/E and P/FCF), but profitability measured by the median ROE is below its historical baseline. Healthcare Providers and Healthcare Technology are moderately overpriced. The former …
Alzheimer’s disease reversed in mice, offering hope for humans, new research shows
Amyloid plaques largely disappeared with the deletion of just a single enzyme.
BIO Statement on President’s Proposed 2019 Budget
We will continue to review these proposals in the coming days and stand ready to work with the administration and members of both parties in Congress to advance policies related to health, agriculture, and energy that will preserve America’s role as the world leader in biotechnology innovation.”.
Puma Biotechnology (NASDAQ:PBYI) PT Lowered to $106.00 at Credit Suisse Group
Puma Biotechnology logo Puma Biotechnology (NASDAQ:PBYI) had its price objective dropped by stock analysts at Credit Suisse Group from $147.00 to $106.00 in a report issued on Wednesday, January 24th. The brokerage presently has an “outperform” rating on the biopharmaceutical company’s …
iShares NASDAQ Biotechnology Index (IBB) Holdings Increased by Neumann Capital …
iShares NASDAQ Biotechnology Index logo Neumann Capital Management LLC grew its holdings in shares of iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 199.9% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned …
Bogart Wealth LLC Has $964000 Stake in iShares NASDAQ Biotechnology Index (IBB)
iShares NASDAQ Biotechnology Index logo Bogart Wealth LLC grew its position in iShares NASDAQ Biotechnology Index (NASDAQ:IBB) by 177.6% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 9,028 …
Puma Biotechnology (NASDAQ:PBYI) Given a $147.00 Price Target at Credit Suisse Group
Credit Suisse Group set a $147.00 price target on Puma Biotechnology (NASDAQ:PBYI) in a report published on Monday, January 22nd. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. Other analysts also recently issued reports about the company. Zacks Investment …
patriciaplag7906 